Nimbus Synergies, a leading Canadian early-stage health technology investor, has led a $2.6 million investment in MetaOptima Technology, a digital health company that is revolutionizing the dermatology and skin care… Read More
SEATTLE, WA — (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (Nasdaq: KDNY) today announced it has entered a collaboration agreement with Ionis Pharmaceuticals, Inc. for the discovery, development and commercialization of… Read More
This authorization is the first authorized treatment of a patient with MDMA outside of a clinical trial in Canadian history VANCOUVER, BC — (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc…. Read More
OTTAWA, ON – Canadian Institutes of Health Research Today, Dr. Michael J. Strong, President of the Canadian Institutes of Health Research (CIHR), announced that Dr. Katherine Frohlich has been appointed Scientific… Read More
Completed enrollment in Phase 2 Clinical Trial; data readout expected during calendar 3Q 2023 120% quarter-over-quarter revenue growth in the commercial BayMedica subsidiary Published a peer-reviewed study showing the anti-inflammatory… Read More
